ClinicalTrials.gov
ClinicalTrials.gov Menu

Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00082667
Recruitment Status : Terminated (PI left VICC)
First Posted : May 19, 2004
Last Update Posted : February 25, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2004
  Actual Study Completion Date : June 2005